基于深度学习的CT自动分割对前列腺癌放疗计划剂量学的影响
本研究使用69例CT图像训练3D U-Net自动分割前列腺、膀胱和直肠,并比较手动与自动分割生成的VMAT计划剂量学差异。自动分割几何性能达先进水平,除1例外剂量分布与参考一致,但γ分析通过率平均85%且几何与剂量学指标无强相关。
要点
- 3D U-Net分割前列腺DSC为0.87(0.03),膀胱0.97(0.01),直肠0.89(0.04)。
- 除1例外,前列腺及外扩3 mm的Dmean和V95与参考剂量分布差异在2%和3 Gy以内。
- γ分析平均通过率85%,几何与剂量学指标间无强统计学显著相关。
核心结论
- 3D U-Net自动分割达到先进几何性能,基于临床相关DVH参数的VMAT计划分析显示除1例外未出现危及器官剂量过高或靶区明显欠量/过量。
- γ分析提示若干病例通过率低,研究强调在标准几何评估之外增加剂量学分析的重要性。
研究设计与样本
- 使用69例CT图像及前列腺、膀胱、直肠勾画数据,以DSC损失训练单标签3D U-Net。
- 对自动与手动分割采用相同优化设置生成VMAT计划,以手动分割为参考评估剂量分布。
主要发现
- 自动分割前列腺DSC为0.87(0.03),膀胱0.97(0.01),直肠0.89(0.04),平均HD和95% HD分别低于1.6(0.4)mm和5(4)mm。
- 膀胱V[公式]和直肠V[公式]的剂量分布一致性分别在[公式]和[公式]以内。
- 前列腺及其3 mm外扩的D[公式]和V[公式]与参考剂量分布一致性在2%和3 Gy以内,但1例例外。
- 平均γ通过率为85%,几何与剂量学指标之间无强统计学显著相关。
关键数值与推荐
- 自动分割几何评估采用DSC、平均HD和95% HD,剂量学评估采用DVH参数和3%/3 mm γ准则(10%剂量截断)。
- 膀胱V[公式]和直肠V[公式]的一致性范围分别为[公式]和[公式]。
- 前列腺及3 mm外扩的D[公式]和V[公式]一致性范围为2%和3 Gy(1例例外)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The evaluation of automatic segmentation algorithms is commonly performed using geometric metrics. An analysis based on dosimetric parameters might be more relevant in clinical practice but is often lacking in the literature. The aim of this study was to investigate the impact of state-of-the-art 3D U-Net-generated organ delineations on dose optimization in radiation therapy (RT) for prostate cancer patients. METHODS: A database of 69 computed tomography images with prostate, bladder, and rectum delineations was used for single-label 3D U-Net training with dice similarity coefficient (DSC)-based loss. Volumetric modulated arc therapy (VMAT) plans have been generated for both manual and automatic segmentations with the same optimization settings. These were chosen to give consistent plans when applying perturbations to the manual segmentations. Contours were evaluated in terms of DSC, average and 95% Hausdorff distance (HD). Dose distributions were evaluated with the manual segmentation as reference using dose volume histogram (DVH) parameters and a 3%/3 mm gamma-criterion with 10% dose cut-off. A Pearson correlation coefficient between DSC and dosimetric metrics, i.e. gamma index and DVH parameters, has been calculated. RESULTS: 3D U-Net-based segmentation achieved a DSC of 0.87 (0.03) for prostate, 0.97 (0.01) for bladder and 0.89 (0.04) for rectum. The mean and 95% HD were below 1.6 (0.4) and below 5 (4) mm, respectively. The DVH parameters, V[Formula: see text] for the bladder and V[Formula: see text] for the rectum, showed agreement between dose distributions within [Formula: see text] and [Formula: see text], respectively. The D[Formula: see text] and V[Formula: see text], for prostate and its 3 mm expansion (surrogate clinical target volume) showed agreement with the reference dose distribution within 2% and 3 Gy with the exception of one case. The average gamma pass-rate was 85%. The comparison between geometric and dosimetric metrics showed no strong statistically significant correlation. CONCLUSIONS: The 3D U-Net developed for this work achieved state-of-the-art geometrical performance. Analysis based on clinically relevant DVH parameters of VMAT plans demonstrated neither excessive dose increase to OARs nor substantial under/over-dosage of the target in all but one case. Yet the gamma analysis indicated several cases with low pass rates. The study highlighted the importance of adding dosimetric analysis to the standard geometric evaluation.
引用
- Kawula M, Purice D, Li M, et al. Dosimetric impact of deep learning-based CT auto-segmentation on radiation therapy treatment planning for prostate cancer. Radiat Oncol. 2022. PMID: 35101068. doi:10.1186/s13014-022-01985-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。